Literature DB >> 24338211

A rare infectious presentation of a temporal bone meningioma.

Abid Qureshi1, Alfredo Quinones-Hinojosa, Wendy Ziai.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24338211      PMCID: PMC4659369          DOI: 10.1007/s11060-013-1319-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  5 in total

1.  Imaging and clinical characteristics of temporal bone meningioma.

Authors:  B E Hamilton; K L Salzman; N Patel; R H Wiggins; A J Macdonald; C Shelton; R C Wallace; J Cure; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 2.  Meningiomas presenting in the temporal bone: the pathways of spread from an intracranial site of origin.

Authors:  C Y Chang; S W Cheung; R K Jackler
Journal:  Otolaryngol Head Neck Surg       Date:  1998-12       Impact factor: 3.497

3.  Otogenic meningitis: a five-year study.

Authors:  B Brydoy; E F Ellekjaer
Journal:  J Laryngol Otol       Date:  1972-09       Impact factor: 1.469

4.  Serous otitis media revealing temporal en plaque meningioma.

Authors:  Denis Ayache; Franco Trabalzini; Philippe Bordure; Benoit Gratacap; Vincent Darrouzet; Sébastien Schmerber; Jean-Pierre Lavieille; Marc Williams; Emmanuel Lescanne
Journal:  Otol Neurotol       Date:  2006-10       Impact factor: 2.311

5.  Primary ear and temporal bone meningiomas: a clinicopathologic study of 36 cases with a review of the literature.

Authors:  Lester D R Thompson; John-Paul Bouffard; Glenn D Sandberg; Hernando Mena
Journal:  Mod Pathol       Date:  2003-03       Impact factor: 7.842

  5 in total
  1 in total

1.  Bacterial meningitis: Aetiology, risk factors, disease trends and severe sequelae during 50 years in Sweden.

Authors:  Nils Block; Pontus Naucler; Philippe Wagner; Eva Morfeldt; Birgitta Henriques-Normark
Journal:  J Intern Med       Date:  2022-04-03       Impact factor: 13.068

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.